Nano-diamino-tetrac

N/A

Report date: 2025/01/26 18:32:03

NME

Base Information

Drug NameNano-diamino-tetrac

Drug Alias NameNanotetracPLGA-(1,5-diaza-oct-8-yl)-Tetracnano-diamino-tetraiodothyroacetic acidPLGA-(1,5-diaza-oct-8-yl)-tetraiodothyroacetic acidpoly[lactic-co-glycolicacid]-(1,5-diaza-oct-8-yl)-Tetrac

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIntegrin alpha-V/beta-3 modulators

TargetsIntegrin alpha-V/beta-3

Therapy Area/IndicationsPancreatic NeoplasmsGlioblastomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNanoPharmaceuticals LLC

China Registration ClassN/A

Develop Information

Active CompaniesNanoPharmaceuticals LLC

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsGlioblastoma

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A